SG52841A1 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
SG52841A1
SG52841A1 SG1996010602A SG1996010602A SG52841A1 SG 52841 A1 SG52841 A1 SG 52841A1 SG 1996010602 A SG1996010602 A SG 1996010602A SG 1996010602 A SG1996010602 A SG 1996010602A SG 52841 A1 SG52841 A1 SG 52841A1
Authority
SG
Singapore
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
SG1996010602A
Other languages
English (en)
Inventor
George Petros Yiannikouros
Hans Richter
Henri Stalder
Ingrid Heinze-Kraus
Paul Hebeisen
Urs Weiss
Valeri Runtz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG52841A1 publication Critical patent/SG52841A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996010602A 1995-09-12 1996-09-11 Cephalosporin derivatives SG52841A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95114304 1995-09-12
EP95114303 1995-09-12

Publications (1)

Publication Number Publication Date
SG52841A1 true SG52841A1 (en) 1998-09-28

Family

ID=26138799

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996010602A SG52841A1 (en) 1995-09-12 1996-09-11 Cephalosporin derivatives

Country Status (15)

Country Link
US (1) US5804577A (fr)
JP (1) JPH09132578A (fr)
KR (1) KR100209839B1 (fr)
CN (1) CN1060778C (fr)
AU (1) AU709077B2 (fr)
CA (1) CA2184971A1 (fr)
CO (1) CO4750667A1 (fr)
CZ (1) CZ251896A3 (fr)
HU (1) HUP9602433A3 (fr)
IL (1) IL119215A0 (fr)
MA (1) MA23970A1 (fr)
NO (1) NO963805L (fr)
PL (1) PL316032A1 (fr)
SG (1) SG52841A1 (fr)
TR (1) TR199600715A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033630B2 (ja) * 1998-06-22 2008-01-16 バジリア ファルマスーチカ アーゲー プロペニルセファロスポリン誘導体
EP1006689B1 (fr) * 1998-11-30 2008-02-06 Matsushita Electric Industries Co., Ltd. Commande de retransmission de paquets utilisant des informations prioritaires
ES2251508T3 (es) * 2000-08-14 2006-05-01 Basilea Pharmaceutica Ag Preparacion de sales de fosfonio sustituidas por 3-pirrolidina lactama n-protegida.
RU2361872C2 (ru) * 2004-05-26 2009-07-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Циннамидное соединение
DE602005019602D1 (de) 2004-10-26 2010-04-08 Eisai R&D Man Co Ltd Amorphe form einer zimtsäureamidverbindung
US20090048448A1 (en) * 2005-11-18 2009-02-19 Ikuo Kushida Salts of cynnamide compound or solvates thereof
CN101309916A (zh) * 2005-11-18 2008-11-19 卫材R&D管理有限公司 制备肉桂酰胺衍生物的方法
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
KR20090016591A (ko) * 2006-05-19 2009-02-16 에자이 알앤드디 매니지먼트 가부시키가이샤 헤테로사이클 타입의 신나미드 유도체
JPWO2007135969A1 (ja) * 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ウレア系−シンナミド誘導体
CL2008000582A1 (es) * 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
US20080306272A1 (en) * 2007-05-16 2008-12-11 Eisai R&D Management Co., Ltd. One-pot methods for preparing cinnamide derivatives
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
BRPI0815773A2 (pt) * 2007-08-31 2019-09-24 Eisai R&D Man Co Ltd composto, e, medicamento.
WO2009096349A1 (fr) * 2008-01-28 2009-08-06 Eisai R & D Management Co., Ltd. Composés cristallins de cinnamide ou sels de ceux-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
JPH09132578A (ja) 1997-05-20
KR100209839B1 (ko) 1999-07-15
HUP9602433A2 (en) 1997-05-28
MA23970A1 (fr) 1997-04-01
IL119215A0 (en) 1996-12-05
PL316032A1 (en) 1997-03-17
US5804577A (en) 1998-09-08
CZ251896A3 (en) 1997-04-16
MX9604017A (es) 1997-07-31
AU6550696A (en) 1997-03-20
KR970015593A (ko) 1997-04-28
HU9602433D0 (en) 1996-10-28
NO963805L (no) 1997-03-13
CN1060778C (zh) 2001-01-17
HUP9602433A3 (en) 2001-04-28
CO4750667A1 (es) 1999-03-31
CN1150950A (zh) 1997-06-04
NO963805D0 (no) 1996-09-11
AU709077B2 (en) 1999-08-19
CA2184971A1 (fr) 1997-03-13
TR199600715A2 (tr) 1997-03-21

Similar Documents

Publication Publication Date Title
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
ZA96228B (en) Indolepiperidine derivatives
SG64953A1 (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HUP9602433A3 (en) Cephalosporin derivatives
HUP9600107A3 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
EP0727426A3 (fr) Dérivés de céphalosporine
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA964470B (en) Cycloalkane-benzylidene derivatives
AU3039895A (en) Cephalosporin derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
HUP9903621A3 (en) Cephalosporin derivatives
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
EP0754668A3 (fr) Dérivés de l'éther fluoro-benzylique
AU1278197A (en) Cephalosporin derivatives
PL324892A1 (en) Aza-antracyclinone derivatives